A new experimental drug, ANB033, shows early promise in protecting people with celiac disease from gluten-induced intestinal damage and symptoms.
The Centre’s pharma push strengthens stent safety, expands clinical trial sites beyond metros and advances emergency care on Maharashtra highways.
Clinical trial site readiness gains focus as AstraZeneca and NIPER Raebareli partner to strengthen research infrastructure across 25 emerging Indian geographies.
The Biocon & Roche settlement clears a legal hurdle for Pebrilzo, highlighting how patent agreements shape biosimilar launch timelines across global markets.
A national survey finds 6 in 10 Indian men are unaware of their prostate cancer screening status, exposing major gaps in awareness and early detection.
Kerala’s Senior Citizens Care Bill, 2026, introduces enforceable standards for geriatric care, regulates elderly care facilities, recognizes living wills, and strengthens protection against abuse.
Indian pharma innovation is gaining momentum as companies and policymakers focus on R&D investment, clinical trials, and new drug development.
Johnson & Johnson doubles down on Ortho breakup plans as a 6% share collapse contrasts with strong pharmaceutical earnings and medical device pressures.
Pharma’s Day of Deals spotlights an AI obesity push, a digital pathology buy, and fresh funds for Indian biotech innovation.
HPV-targeted cancer therapy faces a setback as BioNTech's BNT113 misses its first major clinical trial endpoint in head and neck cancer.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
